跳至主要内容
临床试验/NCT02540005
NCT02540005已完成不适用

Coagulation Disorders After Aneurysmatic Subarachnoid Haemorrhage

Tampere University Hospital1 个研究点 分布在 1 个国家目标入组 32 人开始时间: 2015年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
32
试验地点
1
主要终点
ROTEM analysis: MCF (mm) by EXTEM activators

研究概览

简要总结

The main purpose of this study is to analyse the on-going coagulation process after aSAH. For investigation the investigators use the rotational thromboelastometry (ROTEM) which is a point-of-care test using a variety of activators to provide a targeted and a dynamic analysis of coagulation cascade. This is a prospective, observational clinical study done in 16 aSAH patients treated in Tampere University Hospital intensive care unit and 16 control patients (elective craniotomy due to non-ruptured intracranial aneurysm.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 18 years
  • Acute subarachnoid haemorrhage (confirmed by computed tomography, CT, or cerebrospinal fluid erythrocyte count over 1000 x 106/l) AND confirmed origin either with computed angiography (CTA) or digital subtraction angiography (DSA)
  • Onset of symptoms ≤ 12 hours
  • Expected to stay 72 hours in the ICU

排除标准

  • Pregnancy
  • Any long-term anticoagulant medication, except for low-dose aspirin (<150 mg/day)
  • Known active cancer

结局指标

主要结局

ROTEM analysis: MCF (mm) by EXTEM activators

时间窗: 12 hours

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Annukka Vahtera

MD

Tampere University Hospital

研究点 (1)

Loading locations...

相似试验